Belpointe Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-1,092
| Closed | -$237K | – | 1193 |
|
2021
Q1 | $237K | Sell |
1,092
-670
| -38% | -$145K | 0.02% | 686 |
|
2020
Q4 | $203K | Buy |
+1,762
| New | +$203K | 0.02% | 688 |
|
2020
Q3 | – | Sell |
-1,848
| Closed | -$227K | – | 831 |
|
2020
Q2 | $227K | Buy |
+1,848
| New | +$227K | 0.03% | 485 |
|
2020
Q1 | – | Sell |
-1,294
| Closed | -$135K | – | 830 |
|
2019
Q4 | $135K | Sell |
1,294
-704
| -35% | -$73.4K | 0.02% | 669 |
|
2019
Q3 | $230K | Sell |
1,998
-76
| -4% | -$8.75K | 0.04% | 438 |
|
2019
Q2 | $358K | Buy |
2,074
+204
| +11% | +$35.2K | 0.07% | 298 |
|
2019
Q1 | $315K | Buy |
1,870
+407
| +28% | +$68.6K | 0.06% | 239 |
|
2018
Q4 | $142K | Buy |
1,463
+85
| +6% | +$8.25K | 0.04% | 408 |
|
2018
Q3 | $237K | Buy |
+1,378
| New | +$237K | 0.04% | 411 |
|